United States Peptide Therapeutics Market Report & Forecast 2021-2027

United States Peptide Therapeutics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Peptide Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Peptide Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Peptide Therapeutics Overall Market Size
2.1 United States Peptide Therapeutics Market Size: 2021 VS 2027
2.2 United States Peptide Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide Therapeutics Players in United States Market
3.2 Top United States Peptide Therapeutics Companies Ranked by Revenue
3.3 United States Peptide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Peptide Therapeutics Companies in United States Market, by Revenue in 2020
3.5 Companies Peptide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Therapeutics Players in United States Market
3.6.1 List of Tier 1 Peptide Therapeutics Companies in United States
3.6.2 List of Tier 2 and Tier 3 Peptide Therapeutics Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Peptide Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Oral
4.1.4 Other
4.2 By Type - United States Peptide Therapeutics Revenue & Forecasts
4.2.1 By Type - United States Peptide Therapeutics Revenue, 2016-2021
4.2.2 By Type - United States Peptide Therapeutics Revenue, 2022-2027
4.2.3 By Type - United States Peptide Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Peptide Therapeutics Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application - United States Peptide Therapeutics Revenue & Forecasts
5.2.1 By Application - United States Peptide Therapeutics Revenue, 2016-2021
5.2.2 By Application - United States Peptide Therapeutics Revenue, 2022-2027
5.2.3 By Application - United States Peptide Therapeutics Revenue Market Share, 2016-2027
6 Peptide Therapeutics Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Peptide Therapeutics Introduction
6.1.4 Sanofi Peptide Therapeutics Revenue in United States Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 Teva
6.2.1 Teva Company Details
6.2.2 Teva Business Overview
6.2.3 Teva Peptide Therapeutics Introduction
6.2.4 Teva Peptide Therapeutics Revenue in United States Market (2016-2021)
6.2.5 Teva Recent Developments
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Details
6.3.2 Novo Nordisk Business Overview
6.3.3 Novo Nordisk Peptide Therapeutics Introduction
6.3.4 Novo Nordisk Peptide Therapeutics Revenue in United States Market (2016-2021)
6.3.5 Novo Nordisk Recent Developments
6.4 Takeda
6.4.1 Takeda Company Details
6.4.2 Takeda Business Overview
6.4.3 Takeda Peptide Therapeutics Introduction
6.4.4 Takeda Peptide Therapeutics Revenue in United States Market (2016-2021)
6.4.5 Takeda Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Company Details
6.5.2 Eli Lilly Business Overview
6.5.3 Eli Lilly Peptide Therapeutics Introduction
6.5.4 Eli Lilly Peptide Therapeutics Revenue in United States Market (2016-2021)
6.5.5 Eli Lilly Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Company Details
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Peptide Therapeutics Introduction
6.6.4 AstraZeneca Peptide Therapeutics Revenue in United States Market (2016-2021)
6.6.5 AstraZeneca Recent Developments
6.7 Novartis
6.7.1 Novartis Company Details
6.7.2 Novartis Business Overview
6.7.3 Novartis Peptide Therapeutics Introduction
6.7.4 Novartis Peptide Therapeutics Revenue in United States Market (2016-2021)
6.7.5 Novartis Recent Developments
6.8 AbbVie
6.8.1 AbbVie Company Details
6.8.2 AbbVie Business Overview
6.8.3 AbbVie Peptide Therapeutics Introduction
6.8.4 AbbVie Peptide Therapeutics Revenue in United States Market (2016-2021)
6.8.5 AbbVie Recent Developments
6.9 Ipsen
6.9.1 Ipsen Company Details
6.9.2 Ipsen Business Overview
6.9.3 Ipsen Peptide Therapeutics Introduction
6.9.4 Ipsen Peptide Therapeutics Revenue in United States Market (2016-2021)
6.9.5 Ipsen Recent Developments
6.10 Ferring
6.10.1 Ferring Company Details
6.10.2 Ferring Business Overview
6.10.3 Ferring Peptide Therapeutics Introduction
6.10.4 Ferring Peptide Therapeutics Revenue in United States Market (2016-2021)
6.10.5 Ferring Recent Developments
6.11 Merck
6.11.1 Merck Company Details
6.11.2 Merck Business Overview
6.11.3 Merck Peptide Therapeutics Introduction
6.11.4 Merck Peptide Therapeutics Revenue in United States Market (2016-2021)
6.11.5 Merck Recent Developments
6.12 The Medicines
6.12.1 The Medicines Company Details
6.12.2 The Medicines Business Overview
6.12.3 The Medicines Peptide Therapeutics Introduction
6.12.4 The Medicines Peptide Therapeutics Revenue in United States Market (2016-2021)
6.12.5 The Medicines Recent Developments
6.13 J & J
6.13.1 J & J Company Details
6.13.2 J & J Business Overview
6.13.3 J & J Peptide Therapeutics Introduction
6.13.4 J & J Peptide Therapeutics Revenue in United States Market (2016-2021)
6.13.5 J & J Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Peptide Therapeutics Market Opportunities & Trends in United States Market
Table 2. Peptide Therapeutics Market Drivers in United States Market
Table 3. Peptide Therapeutics Market Restraints in United States Market
Table 4. Key Players of Peptide Therapeutics in United States Market
Table 5. Top Peptide Therapeutics Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Peptide Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Peptide Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Companies Peptide Therapeutics Product Type
Table 9. List of Tier 1 Peptide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Peptide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Peptide Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Peptide Therapeutics Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Peptide Therapeutics Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Peptide Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Peptide Therapeutics Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Peptide Therapeutics Revenue (US$, Mn), 2022-2027
Table 17. Sanofi Company Details
Table 18. Sanofi Business Overview
Table 19. Sanofi Peptide Therapeutics Product
Table 20. Sanofi Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Sanofi Recent Developments
Table 22. Teva Company Details
Table 23. Teva Business Overview
Table 24. Teva Peptide Therapeutics Product
Table 25. Teva Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Teva Recent Developments
Table 27. Novo Nordisk Company Details
Table 28. Novo Nordisk Business Overview
Table 29. Novo Nordisk Peptide Therapeutics Product
Table 30. Novo Nordisk Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Novo Nordisk Recent Developments
Table 32. Takeda Company Details
Table 33. Takeda Business Overview
Table 34. Takeda Peptide Therapeutics Product
Table 35. Takeda Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Takeda Recent Developments
Table 37. Eli Lilly Company Details
Table 38. Eli Lilly Business Overview
Table 39. Eli Lilly Peptide Therapeutics Product
Table 40. Eli Lilly Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Eli Lilly Recent Developments
Table 42. AstraZeneca Company Details
Table 43. AstraZeneca Business Overview
Table 44. AstraZeneca Peptide Therapeutics Product
Table 45. AstraZeneca Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. AstraZeneca Recent Developments
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Peptide Therapeutics Product
Table 50. Novartis Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novartis Recent Developments
Table 52. AbbVie Company Details
Table 53. AbbVie Business Overview
Table 54. AbbVie Peptide Therapeutics Product
Table 55. AbbVie Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. AbbVie Recent Developments
Table 57. Ipsen Company Details
Table 58. Ipsen Business Overview
Table 59. Ipsen Peptide Therapeutics Product
Table 60. Ipsen Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Ipsen Recent Developments
Table 62. Ferring Company Details
Table 63. Ferring Business Overview
Table 64. Ferring Peptide Therapeutics Product
Table 65. Ferring Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Ferring Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Peptide Therapeutics Product
Table 70. Merck Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. The Medicines Company Details
Table 73. The Medicines Business Overview
Table 74. The Medicines Peptide Therapeutics Product
Table 75. The Medicines Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. The Medicines Recent Developments
Table 77. J & J Company Details
Table 78. J & J Business Overview
Table 79. J & J Peptide Therapeutics Product
Table 80. J & J Peptide Therapeutics Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. J & J Recent Developments
List of Figures
Figure 1. Peptide Therapeutics Segment by Type
Figure 2. Peptide Therapeutics Segment by Application
Figure 3. United States Peptide Therapeutics Market Overview: 2020
Figure 4. United States Peptide Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Peptide Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Peptide Therapeutics Revenue in 2020
Figure 7. By Type - United States Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 8. By Application - United States Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 9. Sanofi Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Teva Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Novo Nordisk Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Takeda Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Eli Lilly Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. AstraZeneca Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novartis Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. AbbVie Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Ipsen Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Ferring Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Merck Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. The Medicines Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. J & J Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Thyroid Gland Disorders Treatment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80

Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......

Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......

Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......

Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......

Global Enzyme Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113

According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......

Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84

According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......

Global Hormone Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......

Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs